International Myeloma Foundation(IMF) shared a post on X:
“Targeting GPRC5D to treat myeloma can be highly effective, explains Joseph Mikhael, but we do see some unique side effects.
Learn how we can manage these. Supported by an educational grant from Janssen Biotech, Inc.”
Other articles on International Myeloma Foundation on OncoDaily.